3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Parkinson Disease 4, Autosomal Dominant Lewy Body
8
Carcinoma, Non-Small-Cell Lung
8
Melanoma
7
Squamous Cell Carcinoma of Head and Neck
6
Ovarian Neoplasms
6
Lung Neoplasms
6
Head and Neck Neoplasms
5
Carcinoma, Transitional Cell
4
Stomach Neoplasms
3
Lymphoma
3
Colorectal Neoplasms
3
Carcinoma, Renal Cell
3
Triple Negative Breast Neoplasms
2
Small Cell Lung Carcinoma
2
Neoplasm Metastasis
2
Glioblastoma
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Hepatocellular
2
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thymus Neoplasms
1
Thymoma
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Myelodysplastic Syndromes
1
Microsatellite Instability
1
Interventions
Gemcitabine
5
Paclitaxel
4
Nivolumab
3
cobimetinib
2
atezolizumab
2
adavosertib
2
Ramucirumab
2
N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide
2
Carboplatin
2
zansecimab
1
tocilizumab
1
tivozanib
1
tislelizumab
1
temsirolimus
1
ridaforolimus
1
plocabulin
1
pexidartinib
1
pevonedistat
1
pembrolizumab
1
pamiparib
1
obinutuzumab
1
necitumumab
1
liposomal doxorubicin
1
lenvatinib
1
glasdegib
1
futuximab
1
demplatin pegraglumer
1
birinapant
1
avelumab
1
Temozolomide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Solid Tumors
×
epacadostat
×
Clear all
No trials found.